영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 10mg tablets
alliance healthcare (distribution) ltd - chlordiazepoxide hydrochloride - oral tablet - 10mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 5mg tablets
alliance healthcare (distribution) ltd - chlordiazepoxide hydrochloride - oral tablet - 5mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 5mg tablets
a a h pharmaceuticals ltd - chlordiazepoxide hydrochloride - oral tablet - 5mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 10mg tablets
a a h pharmaceuticals ltd - chlordiazepoxide hydrochloride - oral tablet - 10mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 5mg tablets
dr reddy's laboratories (uk) ltd - chlordiazepoxide hydrochloride - oral tablet - 5mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 5mg tablets
phoenix healthcare distribution ltd - chlordiazepoxide hydrochloride - oral tablet - 5mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 10mg tablets
phoenix healthcare distribution ltd - chlordiazepoxide hydrochloride - oral tablet - 10mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 5mg tablets
waymade healthcare plc - chlordiazepoxide hydrochloride - oral tablet - 5mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlordiazepoxide 5mg tablets
ennogen healthcare ltd - chlordiazepoxide hydrochloride - oral tablet - 5mg
뉴질랜드 -
영어 -
Medsafe (Medicines Safety Authority)
tasmar
inova pharmaceuticals (new zealand) limited - tolcapone 100mg - film coated tablet - 100 mg - active: tolcapone 100mg excipient: calcium hydrogen phosphate ethylcellulose hypromellose iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc sodium laurilsulfate sodium starch glycolate titanium dioxide triacetin - tasmar is indicated for use in combination with levodopa/benserazide and levodopa/carbidopa in parkinson's disease, including both fluctuating and non-fluctuating patients.